email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1936 - 1950
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
AnHeart Approved to Start Two China Trials of Cancer Drug
$5.00
Available
Sorrento Therapeutics Starts Pre-clinical Tests of SARS-CoV-2 Anti-viral
$5.00
Available
Zhejiang Hisun Pharma's Anti-Viral Effective Against COVID-19
$5.00
Available
Yizhun Intelligent Completes $14 Million B Round for AI-based Scaning Diagnosis
$5.00
Available
Roche Starts Global Trial of Actemra in Seriously Ill COVID-19 Patients
$5.00
Available
Hansoh Approved for China Launch of Ameile as Second-Line NSCLC Treatment
$5.00
Available
CanSino Bio Approved to Start China Trial for COVID-19 Vaccine
$5.00
Available
Zai Files for Approval of PARP Inhibitor as First-Line Maintenance Therapy for Ovarian Cancer
$5.00
Available
InnoCare (Beijing) Prices Hong Kong IPO at Top of Range, Raises $288 Million
$5.00
Available
InxMed of Shanghai Doses First Patient in US Trial of FAK Inhibitor
$5.00
Available
BioNTech and Fosun Partner mRNA Vaccine for COVID-19 in $135 Million Deal
$5.00
Available
Sanofi and Regeneron Start US Trial of Rheumatoid Arthritis Drug for COVID-19
$5.00
Available
Moderna Starts Clinical Trial of mRNA COVID-19 Vaccine in Seattle
$5.00
Available
I-Mab to Test Anti-Inflammatory for Cytokine Release Syndrome in COVID-19 Patients
$5.00
Available
Denovo Discovers Biomarker for Triple-Reuptake Depression Treatment
$5.00
Available